By Mrinalika Roy Oct 28 (Reuters) - Women in the US struggling to find hormone replacement treatments to manage menopause ...

Shortages of estrogen patches have spread to injectable and vaginal hormone treatments as demand for menopause therapy rises, ...

Estrogen patches are the most commonly reported shortage in the U.S., but the FDA says it’s working to boost supply.

Demand for menopause drugs is now outpacing supply across multiple estrogen products in the US. After months of tight ...

FDA approved the first generic Climara Pro, a weekly estrogen-progestin patch, as women report trouble filling patches. What ...

Tammy Duckworth, Kirsten Gillibrand and Adam Schiff urge the FDA to address the estradiol patch shortage disrupting menopause ...

For a billionaire, another dollar might not change much. For someone struggling to afford prescription medication, the cost ...

Interest in the hormone treatment — which can involve a combination of estrogen and progestin via pill, transdermal patch, ...

Is it great to have more options for menopause treatment? Yes. Is this one a game changer? Unclear.

A new generic hormone therapy patch used to treat symptoms of menopause will be available following recent FDA approval.

October 26, 2026 U.S. Senator Kirsten Gillibrand (D-NY) pressed the Food and Drug Administration (FDA) on its plan to mitigate the estradiol transdermal patch shortage, which is making it ...

Hot flashes and night sweats usually dominate the conversation around the menopausal transition, but the shifts occurring above the neck can be even more disorienting.